全文获取类型
收费全文 | 1682篇 |
免费 | 130篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 50篇 |
妇产科学 | 76篇 |
基础医学 | 197篇 |
口腔科学 | 122篇 |
临床医学 | 160篇 |
内科学 | 265篇 |
皮肤病学 | 35篇 |
神经病学 | 103篇 |
特种医学 | 36篇 |
外科学 | 306篇 |
综合类 | 8篇 |
预防医学 | 201篇 |
眼科学 | 29篇 |
药学 | 89篇 |
中国医学 | 1篇 |
肿瘤学 | 126篇 |
出版年
2023年 | 19篇 |
2022年 | 22篇 |
2021年 | 57篇 |
2020年 | 43篇 |
2019年 | 53篇 |
2018年 | 44篇 |
2017年 | 40篇 |
2016年 | 42篇 |
2015年 | 51篇 |
2014年 | 61篇 |
2013年 | 77篇 |
2012年 | 97篇 |
2011年 | 97篇 |
2010年 | 50篇 |
2009年 | 39篇 |
2008年 | 59篇 |
2007年 | 84篇 |
2006年 | 74篇 |
2005年 | 74篇 |
2004年 | 63篇 |
2003年 | 54篇 |
2002年 | 38篇 |
2001年 | 39篇 |
2000年 | 45篇 |
1999年 | 36篇 |
1998年 | 15篇 |
1997年 | 6篇 |
1996年 | 17篇 |
1995年 | 18篇 |
1994年 | 16篇 |
1993年 | 9篇 |
1992年 | 29篇 |
1991年 | 29篇 |
1990年 | 29篇 |
1989年 | 24篇 |
1988年 | 26篇 |
1987年 | 32篇 |
1986年 | 29篇 |
1985年 | 18篇 |
1984年 | 27篇 |
1983年 | 11篇 |
1982年 | 7篇 |
1981年 | 6篇 |
1979年 | 20篇 |
1978年 | 14篇 |
1977年 | 13篇 |
1975年 | 8篇 |
1974年 | 7篇 |
1973年 | 7篇 |
1970年 | 5篇 |
排序方式: 共有1815条查询结果,搜索用时 31 毫秒
1.
2.
3.
Gregers Mads Christian Tofte Mikkelsen Søren Lindvig Katrine Prier Brøchner Anne Craveiro 《Neurocritical care》2020,33(1):273-282
Neurocritical Care - For years, the use of ketamine as an anesthetic to patients suffering from acute brain injury has been debated because of its possible deleterious effects on the cerebral... 相似文献
4.
Yanfei L Ma Qingqiang Zeng David W Donley Louis-Georges Ste-Marie J Christopher Gallagher Gail P Dalsky Robert Marcus Erik Fink Eriksen 《Journal of bone and mineral research》2006,21(6):855-864
Transiliac bone biopsies were obtained from 55 women treated with teriparatide or placebo for 12-24 months. We report direct evidence that modeling bone formation at quiescent surfaces was present only in teriparatide-treated patients and bone formation at remodeling sites was higher with teriparatide than placebo. INTRODUCTION: Recombinant teriparatide [human PTH(1-34)], a bone formation agent for the treatment of osteoporosis when given once daily subcutaneously, increases biochemical markers of bone turnover and activation frequency in histomorphometry studies. MATERIALS AND METHODS: We studied the mechanisms underlying this bone-forming action of teriparatide at the basic multicellular unit by the appearance of cement lines, a method used to directly classify surfaces as modeling or remodeling osteons, and by the immunolocalization of IGF-I and IGF-II. Transiliac bone biopsies were obtained from 55 postmenopausal women treated with teriparatide 20 or 40 microg or placebo for 12-24 months (median, 19.8 months) in the Fracture Prevention Trial. RESULTS: A dose-dependent relationship was observed in modeling and mixed remodeling/modeling trabecular hemiosteons. Trabecular and endosteal hemiosteon mean wall thicknesses were significantly higher in both teriparatide groups than in placebo. There was a dose-dependent relationship in IGF-II immunoreactive staining at all bone envelopes studied. The greater local IGF-II presence after treatment with teriparatide may play a key role in stimulating bone formation. CONCLUSIONS: Direct evidence is presented that 12-24 months of teriparatide treatment induced modeling bone formation at quiescent surfaces and resulted in greater bone formation at remodeling sites, relative to placebo. 相似文献
5.
Contractile properties of in situ perfused skeletal muscles from rats with congestive heart failure 总被引:3,自引:0,他引:3
Per Kristian Lunde Esther Verburg Morten Eriksen Ole M. Sejersted 《The Journal of physiology》2002,540(2):571-580
We hypothesized that in congestive heart failure (CHF) slow-twitch but not fast-twitch muscles exhibit decreased fatigue resistance in the sense of accelerated reduction of muscle force during activity. Experiments were carried out on anaesthetized rats 6 weeks after induction of myocardial infarction or a sham operation (Sham). Animals with left ventricular end-diastolic pressure (LVEDP) > 15 mmHg under anaesthesia were selected for the CHF group. There was no muscle atrophy in CHF. Force generation by in situ perfused soleus (Sol) or extensor digitorum longus (EDL) muscles was recorded during stimulation (trains at 5 Hz for 6 s (Sol) or 10 Hz for 1.5 s (EDL) at 10 or 2.5 s intervals, respectively) for 1 h in Sol and 10 min in EDL at 37 °C. Initial force was almost the same in Sol from CHF and Sham rats, but relaxation was slower in CHF. Relaxation times (95–5 % of peak force) were 177 ± 55 and 131 ± 44 ms in CHF and Sham, respectively, following the first stimulation train. After 2 min of stimulation the muscles transiently became slower and maximum relaxation times were 264 ± 71 and 220 ± 45 ms in CHF and Sham, respectively ( P < 0.05 ). After 60 min they recovered to 204 ± 60 and 122 ± 55 ms in CHF and Sham, respectively ( P < 0.05 ). In CHF but not in Sham rats the force of contraction of Sol declined from the second to the sixtieth minute to 70 % of peak force. The EDL of both CHF and Sham fatigued to 24–28 % of initial force, but no differences in contractility pattern were detected. Thus, slow-twitch muscle is severely affected in CHF by slower than normal relaxation and significantly reduced fatigue resistance, which may explain the sensation of both muscle stiffness and fatigue in CHF patients. 相似文献
6.
24-hour ambulatory dual gastroduodenal pH monitoring. The role of acid in duodenal ulcer disease.
下载免费PDF全文
![点击此处可从《Annals of surgery》网站下载免费的PDF全文](/ch/ext_images/free.gif)
A new system for long-term, 24-hour, ambulatory dual gastroduodenal pH monitoring is described. Eighteen patients with active duodenal ulcers and ten healthy subjects were studied. Simultaneous gastric and duodenal bulb pH were measured during fasting, the ingestion of a solid meal, and for the remainder of the 24-hour period. The gastric pH profile was similar for both groups. There was no significant difference between the fasting duodenal bulb pH of the duodenal ulcer (DU) patients and controls. The daytime and nocturnal duodenal acid exposure was similar for both groups. The meal caused a similar pattern of duodenal acidification in both controls and DU patients, and acid neutralization appeared to be effective in DU patients. The role of acid in the duodenal bulb does not appear to be of primary pathophysiologic importance in duodenal ulcer disease. 相似文献
7.
Abstract: This review examines the liver-damaging side effects of anabolic-androgenic steroids (AAS). It seems that AAS can cause development of peliosis hepatis, subcellular changes of hepatocytes, hepatocellular hyperplasia and hepatocellular adenomas. On the other hand, it has not been convincingly proved that AAS can cause development of hepatocellular carcinomas when used in the usual therapeutic doses. Tumours reported as hepatocellular carcinomas caused by AAS seem to be hyperplastic lesions of a benign nature able to regress with withdrawal of the putative agent. The effects of untraditional combinations and high-dose AAS are not yet known, leaving the possibility of a carcinogenic effect in those cases. 相似文献
8.
9.
S. H. Sindrup L. Arendt-Nielsen K. Brøsen P. Bjerring H. R. Angelo B. Eriksen L. F. Gram 《European journal of clinical pharmacology》1992,42(6):587-591
Summary We have studied the hypoalgesic effect of codeine (100 mg) after blocking the hepatic O-demethylation of codeine to morphine via the sparteine oxygenase (CYP2D6) by quinidine (200 mg). The study was performed in 16 extensive metabolizers of sparteine, using a double-blind, randomized, four-way, cross-over design. The treatments given at 3 h intervals during the four sessions were placebo/placebo, quinidine/placebo, placebo/codeine, and quinidine/codeine. We measured pin-prick pain and pain tolerance thresholds to high energy argon laser stimuli before and 1, 2, and 3 h after codeine or placebo.After codeine and placebo, the peak plasma concentration of morphine was 6–62 (median 18) nmol·.l–1. When quinidine pre-treatment was given, no morphine could be detected (<4 nmol·l–1) after codeine. The pin-prick pain thresholds were significantly increased after placebo/codeine, but not after quinidine/codeine compared with placebo/placebo. Both placebo/codeine and quinidine/codeine increased pain tolerance thresholds significantly. Quinidine/codeine and quinidine/placebo did not differ significantly for either pin-prick or tolerance pain thresholds.These results are compatible with local CYP2D6 mediated formation of morphine in the brain, not being blocked by quinidine. Alternatively, a hypoalgesic effect of quinidine might have confounded the results. 相似文献
10.
Reversal of postmenopausal vertebral bone loss by oestrogen and progestogen: a double blind placebo controlled study 总被引:3,自引:0,他引:3
N Munk-Jensen S Pors Nielsen E B Obel P Bonne Eriksen 《British medical journal (Clinical research ed.)》1988,296(6630):1150-1152
Because of uncertainty about the place of hormones in the treatment of postmenopausal bone loss vertebral and forearm bone loss was measured by absorptiometry in early postmenopausal women before and after continuous or sequential treatment with combined oestrogen and progestogen in a double blind placebo controlled trial. Treatment with hormones significantly reversed the vertebral bone loss. The net gain in vertebral bone density amounted to 6.4% a year with continuous supplementation and 5.4% a year with sequential supplementation; the net gain in forearm bone density was lower (3.6% with continuous and 3.7% with sequential supplementation). Before a policy of supplementation with hormones can be recommended to all postmenopausal women with the aim of reducing the incidence of vertebral crush fractures further studies with different doses and combinations of hormones, administered over several years, are needed. 相似文献